Abstract
With the development of glycomics, more and more carbohydrate mimetics were used to investigate the interactions between carbohydrate-proteins, especially in physiological and pathological processes, molecular recognition, signal transduction, cell communication, cell differentiation and developmental events. Recently, because of the drugresistance of microorganisms and the development of antibiotics, the interactions between carbohydrate mimetics and RNAs are becoming hot issue. Aminoglycosides, one family of important antibiotics, can bind with 30S subunits of rRNA to prevent the normal translations of proteins, inhibit the proteins involving in the drug-resistance. In this review, the latest advances in development and applications of aminoglycosides are summarized and the detailed descriptions on the SAR study (Structure-activity relationship) of aminoglycoside derivatives are discussed.
Keywords: Carbohydrate mimetic, aminoglycoside antibiotics, rRNA, structure-activity relationship, enzymatic modification, inhibitor, glycochemistry, Diaminocyclitols, Mycobacterium
Mini-Reviews in Medicinal Chemistry
Title:Development of Aminoglycoside Antibiotics by Carbohydrate Chemistry
Volume: 12 Issue: 14
Author(s): Lina Guo, Yue Wan, Xin Wang, Peng George Wang and Wei Zhao
Affiliation:
Keywords: Carbohydrate mimetic, aminoglycoside antibiotics, rRNA, structure-activity relationship, enzymatic modification, inhibitor, glycochemistry, Diaminocyclitols, Mycobacterium
Abstract: With the development of glycomics, more and more carbohydrate mimetics were used to investigate the interactions between carbohydrate-proteins, especially in physiological and pathological processes, molecular recognition, signal transduction, cell communication, cell differentiation and developmental events. Recently, because of the drugresistance of microorganisms and the development of antibiotics, the interactions between carbohydrate mimetics and RNAs are becoming hot issue. Aminoglycosides, one family of important antibiotics, can bind with 30S subunits of rRNA to prevent the normal translations of proteins, inhibit the proteins involving in the drug-resistance. In this review, the latest advances in development and applications of aminoglycosides are summarized and the detailed descriptions on the SAR study (Structure-activity relationship) of aminoglycoside derivatives are discussed.
Export Options
About this article
Cite this article as:
Guo Lina, Wan Yue, Wang Xin, George Wang Peng and Zhao Wei, Development of Aminoglycoside Antibiotics by Carbohydrate Chemistry, Mini-Reviews in Medicinal Chemistry 2012; 12(14) . https://dx.doi.org/10.2174/138955712803832672
DOI https://dx.doi.org/10.2174/138955712803832672 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
SCYPPred: A Web-Based Predictor of SNPs for Human Cytochrome P450
Protein & Peptide Letters From Protein-Protein Interactions to Rational Drug Design: Are Computational Methods Up to the Challenge?
Current Topics in Medicinal Chemistry Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives
Current Pharmaceutical Analysis Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety New Bioactive Metabolites from the Marine-derived Fungi Aspergillus
Mini-Reviews in Medicinal Chemistry Rediscovering the Antibiotics of the Hive
Recent Patents on Anti-Infective Drug Discovery Meet the Editorial Board Member
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Current Medicinal Chemistry New Anti-Tuberculosis Drugs: Strategies, Sources and New Molecules
Current Medicinal Chemistry Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery
Current Pharmaceutical Design Bacterial Eukaryotic Type Serine-Threonine Protein Kinases: From Structural Biology to Targeted Anti-Infective Drug Design
Current Topics in Medicinal Chemistry Targeting Bacterial RNA Polymerase: Promises for Future Antisense Antibiotics Development
Infectious Disorders - Drug Targets Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection
Current Immunology Reviews (Discontinued) Marine Actinomycetes-derived Natural Products
Current Topics in Medicinal Chemistry Analysis of DNA Microarray Data
Current Topics in Medicinal Chemistry Antibacterial Activities of Flavonoids: Structure-Activity Relationship and Mechanism
Current Medicinal Chemistry Peroxiredons: Tryparedoxin Peroxidase from Leishmania major
Current Regenerative Medicine (Discontinued) Ligustrazine Derivatives. Part 8: Design, Synthesis, and Preliminary Biological Evaluation of Novel Ligustrazinyl Amides as Cardiovascular Agents
Medicinal Chemistry Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients
Current Pharmaceutical Biotechnology Antibacterial Activity of Lipophilic Fluoroquinolone Derivatives
Medicinal Chemistry